Log In
Print
BCIQ
Print
Print this Print this
 

Avinza, morphine

Also known as: formerly Morphelan

  Manage Alerts
Collapse Summary General Information
Company Pfizer Inc.
DescriptionOnce-daily extended-release morphine sulfate capsules
Molecular Target Mu opioid receptor (OPRM1) (MOR)
Mechanism of ActionMu opioid receptor agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard IndicationPain
Indication DetailsTreat chronic, moderate to severe back pain; Treat chronic, moderate to severe osteoarthritis (OA) pain; Treat chronic, moderate to severe pain not associated with cancer; Treat moderate to severe pain; Treat pain; Treat pain in cancer and HIV-infected patients
Regulatory Designation

Partner


 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today